Endo Pharmaceuticals has announced it will remove its Opana ER opioid painkiller from the US market, a month after the FDA requested because of the potential for abuse. Dublin-based Endo said that it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback